Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03107689 · ClinicalTrials.gov registry record

Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
134
Enrollment target

NCT03107689 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 134 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03107689 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
134 participants
Enrollment target

Study Summary

The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.

Interventions

  • OTHER administration of intravenous lipid emulsion

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2012-05
Est. Completion 2018-12

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT03107689

The ClinicalTrials.gov registry entry for NCT03107689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which administration of intravenous lipid emulsion is the first listed.

NCT03107689 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03107689 about?

NCT03107689 is a clinical study titled "Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients". The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will per...

What is the current status of trial NCT03107689?

This trial is currently completed. The enrollment target is 134 participants. The study started on 2012-05. Estimated completion is 2018-12.

What interventions are being tested in trial NCT03107689?

The interventions under investigation include: administration of intravenous lipid emulsion (OTHER).

Who is sponsoring clinical trial NCT03107689?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.